The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Long-term animal experiments with an intraventricular axial flow blood pump.
K Yamazaki; R L Kormos; P Litwak; O Tagusari; T Mori; J F Antaki; M Kameneva; M Watach; L Gordon; H Mukuo; et al. (Profiled Author: Bartley P Griffith)
University of Pittsburgh Medical Center, University of Pittsburgh, PA 15219, USA.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1997;43(5):M696-700.
A miniature intraventricular axial flow blood pump (IVAP) is undergoing in vivo evaluation in calves. The IVAP system consists of a miniature (phi 13.9 mm) axial flow pump that resides within the left ventricular (LV) chamber and a brushless DC motor. The pump is fabricated from titanium alloy, and the pump weight is 170 g. It produces a flow rate of over 5 L/min against 100 mmHg pressure at 9,000 rpm with an 8 W total power consumption. The maximum total efficiency exceeds 17%. A purged lip seal system is used in prototype no. 8, and a newly developed "Cool-Seal" (a low temperature mechanical seal) is used in prototype no. 9. In the Cool-Seal system, a large amount of purge flow is introduced behind the seal faces to augment convective heat transfer, keeping the seal face temperature at a low level for prevention of heat denaturation of blood proteins. The Cool-Seal system consumes < 10 cc purge fluid per day and has greatly extended seal life. The pumps were implanted in three calves (26, 30, and 168 days of support). The pump was inserted through a left thoracotomy at the fifth intercostal space. Two pursestring sutures were placed on the LV apex, and the apex was cored with a myocardial punch. The pump was inserted into the LV with the outlet cannula smoothly passing through the aortic valve without any difficulty. Only 5 min elapsed between the time of chest opening and initiation of pumping. Pump function remained stable throughout in all experiments. No cardiac arrhythmias were detected, even at treadmill exercise tests. The plasma free hemoglobin level remained in the acceptable range. Post mortem examination did not reveal any interference between the pump and the mitral apparatus. No major thromboembolism was detected in the vital organs in Cases 1 or 2, but a few small renal infarcts were detected in Case 3.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
K Yamazaki; P Litwak; O Tagusari; T Mori; K Kono; M Kameneva; M Watach; L Gordon; M Miyagishima; J Tomioka; et al.Artificial organs 1998;22(6):466-74.
Ranjit John; James W Long; H Todd Massey; Bartley P Griffith; Benjamin C Sun; Alfred J Tector; O Howard Frazier; Lyle D JoyceThe Journal of thoracic and cardiovascular surgery 2011;141(4):932-9.
K Yamazaki; P Litwak; R L Kormos; T Mori; O Tagusari; J F Antaki; M Kameneva; M Watach; L Gordon; M Umezu; et al.ASAIO journal (American Society for Artificial Internal Organs : 1992) 1997;43(5):M686-91.
Appears in this Publication
Author of this Publication